Wave Life Sciences .-Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates

Wave Life Sciences (WVE) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of$ 0.28. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -67.86%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.16 per share when it actually produced a loss of $0.25, delivering a surprise of -56.25%.Over the last four quarters ...